Cannabis (Marijuana)
N. Vallejo
MOJ Addiction Medicine & Therapy March 21, 2019 DOI: 10.15406/mojamt.2019.06.00149 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key findings | The article argues that declining perception of cannabis risk over 15 years, along with "recreational" framing, has led to neglect of its psychophysical health risks. It describes D9-THC toxicokinetics, toxicity symptoms, and treatment, notes phencyclidine adulteration ("super yerba") in some Northern Hemisphere countries, and reports that in Argentina cannabis is unauthorized for commercialization and trafficked from Paraguay. CBD is presented as a second-line therapeutic option (cannabis oil). |
Abstract
Cannabis Sativa is the most consumed drug in the world next to alcohol. This article describes its effects, especially that of D9-THC. The perception of the risk of smoking Cannabis has followed a downward curve in the last 15years Granting it to connotation of "recreational" and ignoring or ignoring its risks for psychophysical health. In some countries of the Northern Hemisphere it is usually combined with phencyclidine, being called the mixture "super yerba". In Argentina, until now, it is considered an unauthorized drug for commercialization, and it comes from Paraguay through drug trafficking. It is article contains the symptoms produced by your toxicokinetics and toxicity, as well as the reference of your treatment. This article also provides the therapeutic effects of CBD, the latter always being used as a second line medication (Cannabis Oil).1
Comparable studies
Other narrative reviews on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Causal association between cannabis and psychosis: examination of the evidence | 2004 | Review | |
| Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. General (historical and pharmacological review) | 2018 | Review | |
| Psychiatric effects of cannabis | 2001 | Review | |
| Beyond THC: The New Generation of Cannabinoid Designer Drugs | 2011 | Review | |
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug | 2006 | Review |